You are now leaving the Lundbeck Canada website
Links to sites outside of Lundbeck Canada are provided as resources to visitors and may not reflect Canada regulation or prescribing information. Lundbeck Canada accepts no responsibility for the content of linked sites.
Media
Media relations
Lundbeck seeks an open and active dialogue with the press. Members of the press are always welcome to direct enquiries to our press contacts who work to handle them quickly and professionally.
LATEST RELEASES
- Majority of Canadians on Public Drug Plans Now Eligible for Coverage of Vyepti® (eptinezumab) for the Prevention of Migraine
- Health Canada Approves Otsuka and Lundbeck’s ABILIFY MAINTENA® (aripiprazole for prolonged release injectable suspension) Alternative Initiation Regimen
- 'Montréal's Top Employers' for 2021 Announced
Members of the media seeking further information may contact:
About Lundbeck
H. Lundbeck A/S (HLUNa / HLUNb, HLUNA DC / HLUNB DC) is a global pharmaceutical company specialized in neurological and psychiatric disorders. For more than 70 years, we have been at the forefront of neuroscience research. We are dedicated to advancing brain health and transforming lives.
Millions of people worldwide live with brain diseases, and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement, and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain diseases.
Our approximately 5,500 employees in more than 50 countries are engaged in the entire value chain throughout research, development, production, marketing, and sales. Our pipeline consists of several R&D programs, and our products are available in more than 100 countries. We have research centers in Denmark and the US, and our production facilities are located in Denmark, France, and Italy. Lundbeck generated revenue of DKK 19.9 billion in 2023.
For additional information, we encourage you to connect with us on Twitter at @Lundbeck and via LinkedIn.
Facts about Lundbeck
70 years
In the forefront of neuroscience research
100+
Countries of operation around the world
~5,500
Employees worldwide
19.9b DKK
Of revenue generated in 2023